VTR Stock Recent News
VTR LATEST HEADLINES
Ventas, Inc. (NYSE:VTR ) Q4 2024 Earnings Conference Call February 13, 2025 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & Chief Investment Officer Bob Probst - EVP & CFO Conference Call Participants Omotayo Okusanya - Deutsche Bank Nick Joseph - Citi John Kilichowski - Wells Fargo Juan Sanabria - BMO Capital Markets Vikram Malhotra - Mizuho Richard Anderson - Wedbush Michael Carroll - RBC Capital Markets Ronald Kamdem - Morgan Stanley John Pawlowski - Green Street Wes Golladay - Baird Austin Wurschmidt - KeyBanc Capital Markets Mike Mueller - JPMorgan Nick Yulico - Scotiabank Operator Thank you for standing by. My name is Gail, and I will be your conference operator today.
VTR's Q4 results reflect higher same-store cash NOI due to SHOP same-store average occupancy growth.
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.81 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to FFO of $0.76 per share a year ago.
Ventas posted better-than-expected funds from operations (FFO) for the fourth quarter on Wednesday, driven by strong demand for its assisted living and senior housing properties.
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the full year and fourth quarter ended December 31, 2024. CEO Remarks “Ventas delivered strong financial performance and growth in the fourth quarter and full year 2024 as we executed on our strategy to capture the unprecedented multiyear growth opportunity in senior housing. Our team delivered the third consecutive year of double-digit growth in our senior housing operating portfolio (SHOP.
While VTR's Q4 earnings are likely to have benefited from favorable SHOP operating trends and a well-diversified tenant base, high interest expenses may have hurt it.
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
DOC's Q4 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
The rapidly aging population is a big opportunity for healthcare REITs. Most of them are unfortunately quite expensive. But some opportunities remain. I highlight my top pick.